Purchase Order 75D30121P12238

Award Date 8/6/21
Potential Completion Date 8/31/22
Potential Value $179K
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract, valued at $196,324.31, is for the application of compartment models to forecast diabetes prevalence and assess the impact of various risk factors, including the effect of the COVID-19 pandemic. The contract has a period of performance ending on...
The Department of Health and Human Services, Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to the German non-profit organization Deutsche Diabetes Forschungsgesellschaft E.V. for a $146,715.00 diabetes research project. The contract, which had no set-aside designation, funds mathematical modeling and analysis services to forecast diabetes prevalence and assess the impact of risk factors, including the effect of the COVID-19 pandemic. This award is part of...
This federal contract award to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, provides $199,339.00 in funding for a project to model the future number of people with diabetes in the United States and assess the impact of the COVID-19 pandemic. The work is being performed for the U.S. Centers for Disease Control and Prevention (CDC) and includes compartment modeling, risk score analysis, and projections. This is a Firm Fixed Price purchase order contract with...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $220,266.39 firm fixed price purchase order contract to Deutsche Diabetes Forschungsgesellschaft E.V, a German non-profit organization, to conduct a diabetes study within U.S. adults. The contract, which does not have a set-aside designation, funds mathematical modeling and risk score analysis to forecast diabetes prevalence and assess the impact of various risk factors, including the...
This federal contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, to provide research and modeling services related to the prevalence of late diabetes in Pima Indians in the United States. The contract is a firm fixed-price purchase order with a potential value of $147,876.39 and a completion date of September 29, 2018. Deutsche Diabetes...
This federal contract award, valued at $85,272.00, was issued by the Centers for Disease Control and Prevention (CDC) to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization. The contract is for research services related to "TRUE DIABETES INCIDENCE AND DETECTION IN THE U.S. ADULT PUPLATION." This appears to be a prime contract with no set-aside designation. The services provided include compartment modeling, risk score analysis, and projections on the...
This is a $147,470.09 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to the Baker Heart and Diabetes Institute, a non-profit medical research facility based in Australia. The contract was for research on global and country-specific trends in the incidence of Type 2 diabetes. The contract did not have a set-aside designation. The Baker Heart and Diabetes Institute has previously performed research services as a subcontractor on federal...
This $149,893.46 firm fixed-price purchase order contract was awarded by the U.S. Department of Health and Human Services Centers for Disease Control and Prevention to the Baker Heart and Diabetes Institute, a non-profit research organization, to conduct research on trends in the incidence of young onset Type 2 diabetes. The contract, which did not have a set-aside designation, was completed in February 2019. In addition to this prime contract, Baker Institute has also frequently served as a...
This federal contract award from the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) was made to the Baker Heart And Diabetes Institute, doing business as Baker Institute, a non-profit medical research organization. The $119,000.00 fixed-price purchase order was for research on trends in the incidence of young onset Type 2 diabetes, with a completion date of August 1, 2022. The contract did not utilize a set-aside designation. While Baker Institute has...
This is a $1,400,351.80 firm fixed price BPA call contract awarded by the Centers for Disease Control and Prevention (CDC) to Family Health International (FHI 360), a nonprofit human development organization. The contract is for a Diabetes Management Collaborative program, and it has an ultimate completion date of August 31, 2026. The contract is issued under the CDC's Health Marketing Services Blanket Purchase Agreement (BPA), which allows the agency to procure a wide range of health...

This is a firm fixed price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Deutsche Diabetes Forschungsgesellschaft E.V., a German non-profit organization, to provide research and modeling services related to the impact of changes in diabetes risk score components on future diabetes prevalence. The $178,519.19 contract, awarded on August 6, 2021, does not have a set-aside designation and is scheduled to conclude on August 31, 2022. Past similar awards to this vendor have funded mathematical modeling to forecast diabetes trends and assess the effects of risk factors, including the COVID-19 pandemic. The contract was awarded through a sole source process under the simplified acquisition procedures.

Generated 3/23/24, 10:06 PM